Copyright: ©Author(s) 2026.
World J Clin Oncol. Mar 24, 2026; 17(3): 113226
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.113226
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.113226
Table 3 Human-centered artificial intelligence features for enhancing clinician trust and ensuring safe deployment
| Feature | Purpose | Example | Deployment considerations |
| Feature attribution | Identifies the imaging or clinical features that most influenced the AI’s recommendation | In ablation planning, feature attribution can highlight lesion boundaries, proximity to critical structures, or perfusion metrics that guided probe placement | Should be integrated into procedural consoles with toggleable overlays for real-time validation |
| Uncertainty quantification | Provides confidence scores or probability distributions to help clinicians assess risk and determine whether to rely on or override the output | During catheter navigation, an AI system might suggest a path with 92% confidence, giving the proceduralist a quantifiable basis for trust | Must be displayed in plain language (e.g., “low confidence”) and updated dynamically during the procedure |
| Saliency maps or visual overlays | Highlight relevant anatomical regions on live imaging by overlying AI-derived insights (e.g., tumor margins, vessel segmentation) to support real-time targeting | Enhances targeting precision in ultrasound- or CT-guided procedures by showing which regions the AI model considers most relevant | Requires seamless integration with imaging feeds and adjustable settings |
| Counterfactual examples | Illustrate how small changes in input (e.g., lesion size or location) would alter the AI’s recommendation, helping assess model robustness | Could be used pre-procedurally to simulate alternative probe placements or embolization strategies | Should be available pre-procedurally for simulation and intra-procedurally for real-time adjustment |
- Citation: Almashni SY, Fayek FB, Javens DC, Boulis MT, Makary MS. Evolving and novel applications of artificial intelligence in interventional oncology. World J Clin Oncol 2026; 17(3): 113226
- URL: https://www.wjgnet.com/2218-4333/full/v17/i3/113226.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i3.113226